News

Will Cellebrite DI's (CLBT) Return to Profitability and New CEO Shape Its Investment Story?

Cellebrite DI announced its half-year 2025 results, reporting revenue of US$220.83 million, a turnaround to net income of US$36.88 million, and the appointment of Thomas E. Hogan as CEO, following his ...

Cellebrite (CLBT) Fell Due to Below-Expected Outlook, but Core Trends Persist

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...
TipRanks on MSN6d

Cellebrite DI Announces Shareholder Meeting Amidst Strategic Growth and Leadership Changes

Cellebrite DI ( ($CLBT) ) just unveiled an announcement. On August 15, 2025, Cellebrite DI Ltd. announced its upcoming Annual General Meeting of ...
TipRanks on MSN6d

Cellebrite price target lowered to $22 from $24 at Lake Street

Lake Street analyst Eric Martinuzzi lowered the firm’s price target on Cellebrite (CLBT) to $22 from $24 and keeps a Buy rating on the shares.